Basket cover image
15 handpicked stocks

The Great Retail Price Divide

This collection of stocks represents retailers capitalizing on Amazon's price increases by offering better deals on everyday essentials. These companies were carefully selected by our analysts for their potential to attract budget-conscious shoppers looking for more affordable alternatives.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at juillet 21

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

WMT

Walmart Inc.

WMT

Current price

$101.29

Walmart is actively cutting prices while Amazon raises them, positioning it to attract more price-conscious shoppers.

COST

Costco Wholesale

COST

Current price

$980.85

Costco's membership model and bulk pricing strategy offers significant value compared to increasingly expensive online alternatives.

TGT

Target Corp.

TGT

Current price

$105.36

Target competes directly with Amazon across multiple categories while maintaining competitive pricing on everyday essentials.

About This Group of Stocks

1

Our Expert Thinking

As Amazon raises prices on essential goods by an average of 5%, discount retailers are strategically positioning themselves to capture price-sensitive consumers. This represents a significant shift in retail dynamics, where value-focused companies can potentially gain market share from higher-priced competitors.

2

What You Need to Know

This collection focuses on discount retailers, off-price apparel stores, and warehouse clubs with business models centered on providing value. These companies are directly benefiting from consumers actively seeking relief from inflation through more affordable shopping alternatives.

3

Why These Stocks

Each company in this group was selected for its strong value proposition and potential to absorb market share from higher-priced competitors. These retailers are tactically positioned to capitalize on changing consumer loyalty and spending habits driven by the current competitive pricing environment.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+3.76%

Group Performance Snapshot

3.76%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 3.76% over the next year.

11 of 15

Stocks Rated Buy by Analysts

11 of 15 assets in this group are rated Buy by professional analysts.

8.9% vs 4%

Group Growth vs Bank interest

This group averaged a 8.9% return last month, beating the typical 4% bank rate.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

💰

The Consumer Loyalty Shift

Amazon's 5% price hike on essentials is creating a rare opportunity for competitors to win over price-conscious shoppers. These retailers are perfectly positioned to capture this migration of budget-focused customers.

🔍

Hidden Value Opportunity

While headlines focus on Amazon, these companies are quietly gaining ground by offering better deals on everyday items. Many investors haven't connected these dots yet, giving you a chance to get in early.

📊

Inflation-Beating Potential

As consumers battle rising prices, these retailers offer genuine savings opportunities that are becoming increasingly attractive. Their business models are specifically designed to thrive when shoppers prioritize value above all else.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Orphan Drug Moats: Leaders In Rare Disease

Orphan Drug Moats: Leaders In Rare Disease

The FDA's rejection of PTC Therapeutics' drug for a rare genetic disorder has delayed a new treatment option and created a significant setback for the company. This regulatory decision strengthens the competitive position of companies with already-approved therapies for rare diseases, highlighting the value of a proven drug portfolio.

View stocks
Nvidia's China Chip Pivot

Nvidia's China Chip Pivot

Nvidia is developing a new, compliant AI chip for China, aiming to recapture market share lost to U.S. export controls. This strategic pivot creates a ripple effect, potentially benefiting the entire semiconductor supply chain that supports the production and deployment of this advanced hardware.

View stocks
Navigating The Autonomous Driving Shakeout

Navigating The Autonomous Driving Shakeout

A class-action lawsuit against Tesla regarding its Full Self-Driving claims puts the company's marketing and technology under intense scrutiny. This legal challenge could boost demand for competing autonomous driving technologies, creating opportunities for companies that supply advanced sensors and software.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.